Repurposing systemic RNAi to simplify genome editing in nematodes
重新利用系统性 RNAi 简化线虫基因组编辑
基本信息
- 批准号:10077875
- 负责人:
- 金额:$ 25.13万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-01-01 至 2021-12-31
- 项目状态:已结题
- 来源:
- 关键词:3&apos Untranslated RegionsAddressAdoptionAdultAllelesAnimal ModelAnimalsBackBacteriaBasic ScienceCRISPR/Cas technologyCaenorhabditis elegansCell LineCellsClustered Regularly Interspaced Short Palindromic RepeatsCryopreservationDNADevelopmentDouble-Stranded RNAEnvironmentEnzymesEquipmentFluorescenceGene DeletionGene TargetingGenerationsGenesGeneticGenetic ModelsGenetic ScreeningGenetic studyGuide RNAHermaphroditismLesionLocationMediatingMedicalMethodsMicroinjectionsMutagenesisMutagensMutationNematodaPartner in relationshipPathway interactionsPersonal CommunicationPhasePhenotypePhysiologyPopulationProceduresProcessPropertyRNA InterferenceRNA interference screenResearchSomatic MutationSystemTechnologyTestingTimeTransgenic OrganismsVariantdisease-causing mutationequipment trainingfeedingfunctional genomicsgene functiongene replacementgene therapygenome editinggenome-widein vivomutantnovel strategiesnovel therapeuticsoff-target mutationpreventpromoterrepairedreverse geneticsscreeningskillstooltransmission processwhole genomezygote
项目摘要
Project Summary:
CRISPR/Cas9 technology has revolutionized genome editing and holds great promise for the develop-
ment of new genetic therapies. It is now possible to make precise lesions at defined locations in many model
organisms and cell lines. Physical and regulatory connections identified through numerous “omics” studies can
now be tested directly in vivo, establishing their relative importance to cell and animal physiology. The nema-
tode Caenorhabditis elegans is an exemplary tool for gene function research. The worm is easy to culture, has
a short generation time, and a large brood size. RNAi is highly efficient in this species— pathways exist to take
up double stranded RNA (dsRNA) from the environment and spread it throughout the worm, enabling RNAi by
soaking the worms in dsRNA, or by feeding the worms bacteria that express dsRNA, a property that has ena-
bled routine genome-wide RNAi screening.
Now, thanks to CRISPR / Cas9, it is possible to make both targeted gene deletions and targeted gene
replacements in C. elegans a relatively straightforward way. While this approach is now widely used in many
C. elegans research labs throughout the world, there remains a major limitation. The need to microinject
guides creates a bottleneck that prevents high throughput mutagenesis studies. Microinjection requires both
specialized equipment and training. We propose to combine the most useful features of RNAi, including deliv-
ery by soaking or feeding, with CRISPR/Cas9 mediated genome editing, to eliminate this research bottleneck.
Our approach—termed siCRISPR—will enable genome-wide targeted mutagenesis studies that will enable
functional testing of hypotheses generated through “omics” level sequencing methods.
项目摘要:
CRISPR/CAS9技术已彻底改变了基因组编辑,并为发展带来了巨大的希望 -
新的基因疗法。现在可以在许多模型中在定义的位置进行精确病变
生物和细胞系。通过许多“ OMIC”研究确定的身体和监管联系可以
现在直接在体内进行测试,确定它们对细胞和动物生理学的相对重要性。 NEMA-
秀丽隐杆线虫是基因功能研究的典范工具。蠕虫很容易培养,有
短一代时间,大小很大。 RNAi在该物种中高效 - 存在途径
将双链RNA(dsRNA)脱离环境,并在整个蠕虫中传播,从而使RNAi通过
将蠕虫浸入dsRNA中,或通过喂食表达dsRNA的蠕虫细菌,该特性具有Ena-
BLED常规基因组范围RNAi筛选。
现在,谢谢CRISPR / CAS9,可以既有靶向基因删除又有目标基因
在秀丽隐杆线虫中的替代方法相对简单。虽然现在这种方法已广泛使用
秀丽隐杆线虫研究实验室在世界各地,仍有一个主要限制。需要微型注射
指南会产生一种瓶颈,可防止高通量诱变研究。显微注射需要两者
专业设备和培训。我们建议结合RNAi最有用的特征,包括Deliv-
通过将CRISPR/CAS9介导的基因组编辑浸泡或喂养来消除这项研究瓶颈。
我们的方法 - sicrispr-将实现全基因组的靶向诱变研究,这将使
通过“ OMICS”水平测序方法产生的假设的功能测试。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Sean Patrick Ryder其他文献
Sean Patrick Ryder的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Sean Patrick Ryder', 18)}}的其他基金
Post-transcriptional regulation of germline mRNAs in C. elegans
线虫种系 mRNA 的转录后调控
- 批准号:
10390502 - 财政年份:2022
- 资助金额:
$ 25.13万 - 项目类别:
Post-transcriptional regulation of germline mRNAs in C. elegans
线虫种系 mRNA 的转录后调控
- 批准号:
10610874 - 财政年份:2022
- 资助金额:
$ 25.13万 - 项目类别:
Repurposing systemic RNAi to simplify genome editing in nematodes
重新利用系统性 RNAi 简化线虫基因组编辑
- 批准号:
9916037 - 财政年份:2020
- 资助金额:
$ 25.13万 - 项目类别:
Comparative HTS to identify small molecule effectors of cell fate specification
比较 HTS 来识别细胞命运规范的小分子效应物
- 批准号:
8636032 - 财政年份:2012
- 资助金额:
$ 25.13万 - 项目类别:
Comparative HTS to identify small molecule effectors of cell fate specification
比较 HTS 来识别细胞命运规范的小分子效应物
- 批准号:
8293883 - 财政年份:2012
- 资助金额:
$ 25.13万 - 项目类别:
Comparative HTS to identify small molecule effectors of cell fate specification
比较 HTS 来识别细胞命运规范的小分子效应物
- 批准号:
8449117 - 财政年份:2012
- 资助金额:
$ 25.13万 - 项目类别:
RNA recognition by maternal gene silencers in nematodes
线虫母体基因沉默子对 RNA 的识别
- 批准号:
8010022 - 财政年份:2010
- 资助金额:
$ 25.13万 - 项目类别:
RNA recognition by maternal gene silencers in nematodes
线虫母体基因沉默子对 RNA 的识别
- 批准号:
7596490 - 财政年份:2008
- 资助金额:
$ 25.13万 - 项目类别:
RNA recognition by maternal gene silencers in nematodes
线虫母体基因沉默子对 RNA 的识别
- 批准号:
8033737 - 财政年份:2008
- 资助金额:
$ 25.13万 - 项目类别:
RNA recognition by maternal gene silencers in nematodes
线虫母体基因沉默子对 RNA 的识别
- 批准号:
8231442 - 财政年份:2008
- 资助金额:
$ 25.13万 - 项目类别:
相似海外基金
Activity-Dependent Regulation of CaMKII and Synaptic Plasticity
CaMKII 和突触可塑性的活动依赖性调节
- 批准号:
10817516 - 财政年份:2023
- 资助金额:
$ 25.13万 - 项目类别:
Emerging mechanisms of viral gene regulation from battles between host and SARS-CoV-2
宿主与 SARS-CoV-2 之间的战斗中病毒基因调控的新机制
- 批准号:
10725416 - 财政年份:2023
- 资助金额:
$ 25.13万 - 项目类别:
Genetic and pharmacologic elimination of myotonia from myotonic dystrophy type 1
通过遗传和药物消除 1 型强直性肌营养不良引起的肌强直
- 批准号:
10750357 - 财政年份:2023
- 资助金额:
$ 25.13万 - 项目类别:
Development of Utrophin Site Blocking Oligos (SBOs) to Treat Duchenne Muscular Dystrophy (DMD)
开发 Utropin 位点封闭寡核苷酸 (SBO) 来治疗杜氏肌营养不良症 (DMD)
- 批准号:
10678195 - 财政年份:2023
- 资助金额:
$ 25.13万 - 项目类别: